To determine the Effectiveness of current management for the Prophylaxis of Postoperative Atrial Fibrillation in Cardiac Surgeries
Keywords:
Postoperative atrial fibrillation, Cardiac Surgery, Valvular Surgery, CABGAbstract
Postoperative atrial fibrillation is a very common surgical complication encountered in patients undergoing Cardiac Surgery including Coronary Artery Bypass Grafting and Valvular Surgeries, which leads to increase hospital stay and burden on health care providers. The aim of this review study was to to determine the effectiveness of current management for the Prophylaxis of Postoperative Atrial Fibrillation in Cardiac Surgeries and to propose a possible prophylaxis to prevent POAF. 21 research papers were selected and brought under review after carefully considering the current day evidence for prophylaxis and each having its scientific evidence and background. The papers were carefully reviewed and findings were given in favour of Amiodarone, Ascorbate and B-Blockers including Sotalol. This can rightly be concluded from this study that prophylaxis with Ascorbate for 5 days prior to cardiac surgery along with the use of Amiodarone 1.2 g before surgery and 600 mg/day till 3rd post op day and protocol for B-Blockers will significantly reduce POAF. Also POAF is a clinical complication which needs further studies and research to evaluate the effectiveness of the current management for its prevention.
References
Lauer MS, Eagle KA, Buckley MJ, DeSanctis RW. Atrial fibrillation following coronary artery bypass surgery. Prog Cardiovasc Dis 1989; 31: 367–78.
Groves PH, Hall RJ. Atrial tachyarrhythmias after cardiac surgery. Eur Heart J 1991; 12: 458–63.
Hashimoto K, Ilstrup DM, Schaff HV. Influence of clinical and hemodynamic variables on risk of supraventricular tachycardia after coronary artery bypass. J Thorac Cardiovasc Surg 1991; 101: 56–65.
Ommen SR, Odell JA, Stanton MS. Atrial arrhythmias after cardiothoracic surgery. N Engl J Med. 1997;336:1429–1434.
Quader MA, McCarthy PM, Gillinov AM, Alster JM, Cosgrove DM III, Lytle BW, Blackstone EH. Does preoperative atrial fibrillation reduce survival after coronary artery bypass grafting? Ann Thorac Surg 2004; 77:1514–1522.
Bessissow A, Khan J, Devereaux PJ, Alvarez-Garcia J, Alonso-Coello P. Postoperative atrial fibrillation in non-cardiac and cardiac surgery: an overview. J Thromb Haemost 2015; 13(Suppl. 1): S304–S12.
Creswell LL, Schuessler RB, Rosenbloom M, Cox JL. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg 1993;56:539–549.
Villareal RP, Hariharan R, Liu B, Kar B, Lee VV, Elayda M, Lopez JA, Rasekh A, Wilson JM, Massumi A. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol 2004;43:742–748.
Aranki SF, Shaw DP, Adams DH, Rizzo RJ, Couper GS, VanderVliet M, Collins JJ Jr, Cohn LH, Burstin HR. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation 1996;94:390–397.
Tamis JE, Steinberg JS. Atrial fibrillation independently prolongs hospital stay after coronary artery bypass surgery. Clin Cardiol 2000; 23:155–159.
Borzak S, Tisdale JE, Amin NB, Goldberg AD, Frank D, Padhi ID, Higgins RS. Atrial fibrillation after bypass surgery: does the arrhythmia or the characteristics of the patients prolong hospital stay? Chest 1998;113:1489–1491.
Reed G III, Singer DE, Picard EH, DeSanctis RW. Stroke following coronary-artery bypass surgery. A case-control estimate of the risk from carotid bruits. N Engl J Med 1988;319:1246–1250.
Aranki SF, Shaw DP, Adams DH, et al. Predictors of atrial fibrillation after coronary artery surgery. Circulation. 1996;94:390–397.
Burgess DC, Kilborn MJ, Keech AC (2006) Interventions for prevention of post- operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. Eur Heart J 27:2846–2857.
Leitch JW, Thomson D, Baird DK, et al. The importance of age as a predictor of atrial fibrillation and flutter after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1990;100:338 –342.
Crosby LH, Pifalo WB, Woll KR, et al. Risk factors for atrial fibrillation after coronary artery bypass grafting. Am J Cardiol. 1990;66:1520 –1522.
Mathew JP, Parks R, Savino JS, et al, for the Multicenter Study of Perioperative Ischemia Research Group. Atrial fibrillation following coronary artery bypass graft surgery. JAMA. 1996;276:300 –306.
Buxton AE, Josephson ME. The role of P wave duration as a predictor of postoperative atrial arrhythmias. Chest. 1981;80:68–73
Daubert C, Berder V, Gras D, et al. Atrial tachyarrhythmias associated with high degree interatrial conduction block: prevention by permanent atrial resynchronization. Eur J Card Pacing Electrophysiol.1994;1:35–44.
Capucci CA, Frabetti L, Turinetto B, et al. Fibrillazione atriale nei post operati de bypass aorto-coronarica. G Ital Cardiol. 1987;17:575–582.
Daubert C, Berder V, Gras D, et al. Atrial tachyarrhythmias associated with high degree interatrial conduction block: prevention by permanent atrial resynchronization. Eur J Card Pace Electrophysiol. 1994;1:35– 44.
Fan K, Lee KL, Chiu CS, et al : Effects of biatrial pacing in prevention of postoperative atrial fibrillation after coronary artery bypass surgery. Circulation.2000;102:755–760.
Levy T, Fotopoulos G, Walker S, Rex S, Octave M, Paul V, et al. Randomized controlled study investigating the effect of biatrial pacing in prevention of atrial fibrillation after coronary artery bypass grafting. Circulation2000;102:1382-7
Pasceri V, Patti G, Nusca A, Pristipino C, Richichi G, Di Sciascio G. A randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study. Circulation. 2004;110:674–678.
Patti G, Colonna G, Pasceri V, Lassandro Pepe L, Montinaro A, Di Sciascio G. A randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study. Circulation. 2005;111:2099 –2106.
Patti G, Chello M, Candura D, et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation. 2006;114(14):1455–1461.
Zheng H, Xue, Song, Hu Z, et al. The Use of Statins to Prevent Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting: A Meta-analysis of 12 Studies. Journal of Cardiovascular Pharmacology. 2014;64(3):285-292.
Saso S., Vecht J.A., Rao C. Statin therapy may influence the incidence of postoperative atrial fibrillation what is the evidence? Tex Heart Inst J. 2009;36:521–529.
Mozaffarian D., Psaty B.M., Rimm E.B.; Fish intake and risk of incident atrial fibrillation. Circulation. 110 2004:368-373
Gaudino M, Andreotti F, Zamparelli R, et al. The 174G/C interleukin-6 polymorphism influences post-operative interleukin-6 levels and post-operative atrial fibrillation. Is atrial fibrillation an inflammatory complication? Circulation 2003;108 Suppl II:II195–9.
Endres S, Ghorbani R, Kelley VE, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989;320:265–71.
Calò L, Bianconi L, Colivicchi F, et al. N-3 Fatty Acids for the Prevention of Atrial Fibrillation After Coronary Artery Bypass Surgery: A Randomized, Controlled Trial. J Am Coll Cardiol.2005;45(10):1723-1728.
Abdelhadi RH, Gurm HS, VanWagoner DR, Chung MK. Relation of an exaggerated rise in white blood cells after coronary bypass or cardiac valve surgery to development of atrial fibrillation postoperatively. Am J Cardiol. 2004;93:1176 –1178.
Imazio M, Trinchero R, Brucato A, Rovere ME, Gandino A, Cemin R, Ferrua S, Maestroni S, Zingarelli E, Barosi A, Simon C, Sansone F, Patrini D, Vitali E, Ferrazzi P, Spodick DH, Adler Y; COPPS Investigators. COlchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS): a multicentre, randomized, double-blind, placebocontrolled trial. Eur Heart J. 2010;31:2749 –2754.
Imazio M, Brucato A, Ferrazzi P, Rovere ME, Gandino A, Cemin R, Ferrua S, Belli R,Maestroni S, Simon C, Zingarelli E, Barosi A, Sansone F, Patrini D, Vitali E, Trinchero R, Spodick DH, Adler Y; COPPS Investigators. Colchicine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy. Circulation. 2011;124:2290–2295. doi: 10.1161/CIRCULATIONAHA.111.026153.
Lin PH, Lee SH, Su CP, Wei YH. Oxidative damage to mitochondrial DNA in atrial muscle of patients with atrial fibrillation. Free Radic Biol Med 2003;35:1310–1318.
Mihm MJ, Yu F, Carnes CA, Reiser PJ, McCarthy PM, Van Wagoner DR, Bauer JA. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 2001;104: 174–180.
Kim YH, Lim DS, Lee JH, Lim DS, Shim WJ, Ro YM, Park GH, Becker KG, Cho-Chung YS, Kim MK. Gene expression profiling of oxidative stress on atrial fibrillation in humans. Exp Mol Med 2003;35:336–349.
Ozaydin M, Dogan A, Varol E, Kucuktepe Z, Dogan A, Ozturk M, Altinbas A. Statin use before by-pass surgery decreases the incidence and shortens the duration of postoperative atrial fibrillation. Cardiology 2007;107:117–121.
Kumagai K, Nakashima H, Saku K. The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model. Cardiovasc Res 2004; 62:105–111.
Korantzopoulos P, Kolettis TM, Kountouris E, Dimitroula V, Karanikis P, Pappa E, Siogas K, Goudevenos JA. Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation. Int J Cardiol 2005;102:321–326.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e257–e354
Arfsten D, Johnson E, Thitoff A, Jung A, Wilfong E, Lohrke S, Bausman T, Eggers J, Bobb A. Impact of 30-day oral dosing with N-acetyl-L-cysteine on Sprague-Dawley rat physiology. Int J Toxicol 2004;23:239–247.
Ozaydin M, Peker O, Erdogan D, et al. N-acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study. European Heart Journal Mar 2008, 29 (5) 625-631
Mihm MJ, Yu F, Carnes CA, Reiser PJ, McCarthy PM, Van Wagoner DR, Bauer JA. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation. 2001;104:174 –180.
Carnes CA, Chung MK, Nakayama T, Nakayama H, Baliga RS, Piao S. et al. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res. 2001;89(6):E32–8. doi: 10.1161/hh1801.097644.
Ebade A, Taha WS, Saleh RH, Fawzy A. Ascorbic acid versus magnesium for the prevention of atrial fibrillation after coronary artery bypass grafting surgery. Egypt J Cardiothorac Anesth 2014;8:59-65
Chun S, Sager P, Stevenson W, Nademanee K, Middlekauff H, Singh B. Amiodarone is highly effective in maintaining NSR in refractory atrial fibrillation/flutter. J Am Coll Cardiol 1993;21:203A.
Middlekauff HR, Wiener I, Stevenson WG. Low-dose amiodarone for atrial fibrillation. Am J Cardiol 1993;72:75F-81F.
Banach M, Rysz J, Drozdz JA, Okonski P, Misztal M, Barylski M, Irzmanski R, Zaslonka J: Risk factors of atrial fibrillation following coronary artery bypass grafting: a preliminary report. Circ J 2006, 70(4):438-41.
Emile G. Daoud, M.D., S. Adam Strickberger, M.D., K. Ching Man, D.O., Rajiva Goyal, M.D., G. Michael Deeb, M.D., Steven F. Bolling, M.D., Francis D. Pagani, M.D., Cynthia Bitar, R.N., Marc D. Meissner, M.D., and Fred Morady, M.D. N Engl J Med 1997; 337:1785-1791. DOI: 10.1056/NEJM199712183372501
Treggiari-Venzi MM, Waeber JL, Perneger TV, Suter PM, Adamec R, Romand JA. Intravenous amiodarone or magnesium sulphate is not cost-beneficial prophylaxis for atrial fibrillation after coronary artery bypass surgery. Br J Anaesth. 2000;85:690–695. doi: 10.1093/bja/85.5.690.
Tiryakioglu O, Demirtas S, Ari H, Tiryakioglu SK, Huysal K, Selimoglu O, et al. Magnesium sulphate and amiodarone prophylaxis for prevention of postoperative arrhythmia in coronary by-pass operations. J Cardiothorac Surg. 2009;4:8.
Booth JV, Phillips-Bute B, McCants CB, et al. Low serum magnesium level predicts major adverse cardiac events after coronary artery bypass graft surgery. Am Heart J 2003; 145: 1108-13.
Kaplan M, Kut MS, Icer UA, Demirtas MM. Intravenous magnesium sulfate prophylaxis for atrial fibrillation after coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2003;125:344–352. doi: 10.1067/mtc.2003.108.
R. C. Cook, K. H. Humphries, K. Gin et al., “Prophylactic intravenous magnesium sulphate in addition to oral β-blockade does not prevent atrial arrhythmias after coronary artery or valvular heart surgery a randomized, controlled trial,” Circulation, vol. 120, no. 1, pp. S163–S169, 2009.
Dabrowski W, Rzecki Z, Sztanke M, et al. The efficiency of magnesium supplementation in patients undergoing cardiopulmonary bypass: changes in serum magnesium concentrations and atrial fibrillation episodes. Magnes Res 2008;21:205–17
Fanning WJ, Thomas CS Jr, Roach A, Tomichek R, Alford WC, Stoney WS Jr. Prophylaxis of atrial fibrillation with magnesium sulfate after coronary artery bypass grafting. Ann Thorac Surg.1991;52:529–533. doi: 10.1016/0003-4975(91)90918-G.
Burgess DC, Kilborn MJ, Keech AC. Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. Eur Heart J. 2006;27(23):2846–2857. doi: 10.1093/eurheartj/ehl272.
Crystal E, Connolly SJ, Sleik K, Ginger TJ, Yusuf S. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis.Circulation. 2002;106:75–80.
Archbold RA, Zaman AG. Magnesium for atrial fibrillation after coronary artery bypass graft surgery: its role in aetiology and prevention. Crit Care Resusc. 2000 Dec;2(4):260-8.
Weber, U.K., Osswald, S., Huber, M. et al, Selective versus non-selective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery (is there a need for pre-operative risk stratification?) . Eur Heart J. 1998;19:794–800.
Dunning J, Treasure T, Versteegh M, Nashef S, EACTS Audit and Guidelines Committee: Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery. European Journal of Cardio-thoracic Surgery 2006, 30:852-872.
Koniari I, Apostolakis E, Rogkakou C, Baikoussis NG, Dougenis D. Pharmacologic prophylaxis for atrial fibrillation following cardiac surgery: a systematic review. J Cardiothorac Surg. 2010;30:121. doi: 10.1186/1749-8090-5-121.
Wang HS, Wang ZW, Yin ZT (2014) Carvedilol for prevention of atrial fibrillation after cardiac surgery: a meta-analysis. PLoS One 9: e94005 doi: 10.1371/journal.pone.0094005
Ascione R, Caputo M, Calori G, et al. Predictors of atrial fibrillation after conventional and beating heart coronary surgery. Circulation. 2000;102: 1530–1535.
Buffolo E, Silva de Andrade JC, Rodrigues Branco JN, et al. Coronary artery bypass grafting without cardiopulmonary bypass. Ann Thorac Surg. 1996;61:63–66.
Cohn WE, Sirois CA, Johnson RG. Atrial fibrillation after minimally invasive coronary artery bypass grafting: a retrospective, matched study. J Thorac Cardiovasc Surg. 1999;117:298–301.
Abreu JE, Reilly J, Salzano RP, et al. Comparison of frequencies of atrial fibrillation after coronary artery bypass grafting with and without the use of cardiopulmonary bypass. Am J Cardiol. 1999;83:775–776.
Gaudino M, Andreotti F, Zamparelli R, et al. The −174G/C Interleukin-6 Polymorphism Influences Postoperative Interleukin-6 Levels and Postoperative Atrial Fibrillation. Is Atrial Fibrillation an Inflammatory Complication? Circulation. 2003;108:II-195-II-199.
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 THE STETHO
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
www.icmje.org
www.issn.org
